102 results
management diagnosis treatment pharmacology infections opportunistic prevention algorithm nephrology differential hepatology endocrinology criteria dka hypomagnesemia oncology syndrome bacterial diabetes gastroenterology
IDSA Treatment Recommendations for Cryptococcal Meningoencephalitis in Human Immunodeficiency Virus Infected Individuals Induction therapy: • AmBd (0.7–1.0
IDSA Treatment Recommendations ... AmBd (0.7–1.0 mg ... flucytosine (100 mg ... Meningoencephalitis #IDSA ... #cryptococcus #HIVAIDS
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days) Preferred
IDSA Recommendations ... Fluconazole 100 mg ... buccal tablet 50 mg ... candida #mucosal #IDSA ... opportunistic #infections #HIVAIDS
The Laboratory Risk Indicator for Necrotizing Fasciitis (LRINEC) Scoring System CRP (mg/dL), WBC (per mm3), Hemoglobin (g/dL),
Scoring System CRP (mg ... /dL), WBC (per ... , Creatinine (mg ... /dL), Glucose ... (mg/dL), Score
Ranson's Criteria in Pancreatitis At Admission: - Age > 55 years - WBCs >
Glucose > 200 mg ... /dl - LDH > 350 ... - BUN rise > 5 mg ... /dl - Calcium ... < 8 mg/dl -
IDSA Recommendations for Preventing and Treating Bacterial Enteric Infections in HIV-AIDS Preventing Bacterial Enteric Illness: • Antimicrobial
IDSA Recommendations ... PO (or 400 mg IV ... PO (or 400 mg IV ... Enteric #Bacterial #IDSA ... opportunistic #infections #HIVAIDS
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS Preventing 1st Episode of Penicilliosis (Primary
IDSA Recommendations ... Itraconazolea 200 mg ... itraconazolea 200 mg ... Penicilliosis #IDSA ... opportunistic #infections #HIVAIDS
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS • Pneumocystis pneumonia (PCP)
IDSA - Prophylaxis ... Infections #OIs #HIVAIDS ... #IDSA #management
Acute Kidney Injury - RIFLE and AKIN Criteria for Diagnosis and Classification of AKI • AKIN
Increase in SCr ≥ 0.3 mg ... /dL or increase ... /dL with an acute ... increase of ≥ 0.5 mg ... /dL; or on RRT
IDSA Recommendations for Treating Isospora belli Infection in HIV-AIDS Treating Isospora belli Infection General Management Considerations: • Fluid
IDSA Recommendations ... /800 mg) PO (or ... /800 mg) PO (or ... IsosporaBelli #IDSA ... opportunistic #infections #HIVAIDS
Classification of Tumor Lysis Syndrome (TLS) and Treatment of Metabolic Abnormalities of TLS Laboratory TLS: • Uric
Uric acid ≥ 8.0 mg ... /dL • Potassium ... ≥ 6.0 mEq/dL ... Phosphorus ≥ 4.6 mg ... ≤ 7.0 mg/dL Clinical
No results found for "mg/dL hivaids idsa"
Try removing search terms or sorting by relevance
Or Upload an image for you and others searching for #mg/dL #hivaids #idsa